Re-resection rates in Crohn’s disease patients are significantly influenced by disease activity and stoma reversals. The study reveals that early initiation of biologic therapy after primary resection can reduce the risk of re-resection for specific disease phenotypes. Factors such as disease location, behavior, smoking, and perianal disease also play a role in re-resection. These findings emphasize the potential of biologic therapy as a disease-modifying strategy for certain patient subgroups.
Journal Article by Poulsen A, Rasmussen J (…) Seidelin JB et 17 al. in J Crohns Colitis
© The Author(s) 2024. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.